RE:RE:RE:The vote,,I see our future more like this,,,,,,the vote gets the numbers to carry out the deal,,,,,Biodexa begins to trade on the NASDAQ,,,,there is no interest by the market and as a few months pass the share price errodes to the point of requireing a reverse split which gets the outstanding share numbers below the 1 billlion..,,the previous downtrend of Midatech forms the future trend for Biodexa ...maybe several reverse splits occur over the course of the next year/s as their tech data fails to impress due to poor trial design ( a favorite in this industry) or other,,and also due to competition from outside sources....Biodexa runs out of money once again with little to no interest from the Market and more financing takes place but just enuff to keep the lights on as we once again await that so elusive impressive data. Biodexa ends up delisted and becomes an obscure entity. If there is any interest in the combined technologies it is taken out and private hands begin to stir the pot with its road map for success. We shareholders get absloutely slaughtered. Meanwhile those in the chairs of management pad their personal bank accounts and shrug their shoulders!
If their is optimism for a substantial win down the road with this arrangement its in much greater favour of the other parties involved, We are the ones who get the least reward if there is ever a win situation in the future of Biodexa!!,,if it will even exist in a few years.
So we here on the Far East Coast are voting,,,,, NO,,,,,,,!